Literature DB >> 18159424

Canada's first universal varicella immunization program: Lessons from Prince Edward Island.

Lamont Sweet1, Peggy Gallant, Marie Morris, Scott A Halperin.   

Abstract

A live attenuated varicella vaccine was licensed in Canada in December 1998. The first universal varicella immunization program in Canada was initiated in Prince Edward Island in 2000. Students in grades one to six without a history of varicella were offered the vaccine, administered by Public Health Nurses, in school clinics during February and March 2000. The acceptance rate ranged from 29.1% of all grade one students to 9.8% of all grade six students; overall, 18.8% of students received the vaccine. A universal program for children 12 months of age was introduced on April 1, 2000 and catch-up clinics for those between 12 months of age and those in grade one were introduced in June 2000. Repeated media announcements and the cooperation of staff in schools and daycare facilities assisted in informing parents about the availability of the vaccine. Vaccine-associated adverse events have been uncommon and the vaccine has been well accepted.

Entities:  

Keywords:  Chickenpox; Chickenpox vaccine; Varicella; Varicella vaccine

Year:  2003        PMID: 18159424      PMCID: PMC2094900          DOI: 10.1155/2003/904351

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  13 in total

1.  Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother.

Authors:  M B Salzman; R G Sharrar; S Steinberg; P LaRussa
Journal:  J Pediatr       Date:  1997-07       Impact factor: 4.406

2.  A long-term prospective study of varicella vaccine in healthy children.

Authors:  C E Johnson; T Stancin; D Fattlar; L P Rome; M L Kumar
Journal:  Pediatrics       Date:  1997-11       Impact factor: 7.124

3.  Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-R II, VARIVAX and TETRAMUNE in healthy children vs. concomitant injections of M-M-R II and TETRAMUNE followed six weeks later by VARIVAX.

Authors:  H R Shinefield; S B Black; B O Staehle; T Adelman; K Ensor; A Ngai; C J White; S R Bird; H Matthews; B J Kuter
Journal:  Pediatr Infect Dis J       Date:  1998-11       Impact factor: 2.129

4.  Towards universal childhood immunization against chickenpox?

Authors:  B J Law
Journal:  Paediatr Child Health       Date:  2000-07       Impact factor: 2.253

Review 5.  American Academy of Pediatrics. Committee on Infectious Diseases. Varicella vaccine update.

Authors: 
Journal:  Pediatrics       Date:  2000-01       Impact factor: 7.124

6.  Cost of chickenpox in Canada: part I. Cost of uncomplicated cases.

Authors:  B Law; C Fitzsimon; L Ford-Jones; N MacDonald; P Déry; W Vaudry; E Mills; S Halperin; A Michaliszyn; M Rivière
Journal:  Pediatrics       Date:  1999-07       Impact factor: 7.124

7.  Cost of chickenpox in Canada: part II. Cost of complicated cases and total economic impact. The Immunization Monitoring Program-Active (IMPACT).

Authors:  B Law; C Fitzsimon; L Ford-Jones; J McCormick; M Rivière
Journal:  Pediatrics       Date:  1999-07       Impact factor: 7.124

8.  The postmarketing safety profile of varicella vaccine.

Authors:  R G Sharrar; P LaRussa; S A Galea; S P Steinberg; A R Sweet; R M Keatley; M E Wells; W P Stephenson; A A Gershon
Journal:  Vaccine       Date:  2000-11-22       Impact factor: 3.641

9.  Postmarketing evaluation of the safety and effectiveness of varicella vaccine.

Authors:  S Black; H Shinefield; P Ray; E Lewis; J Hansen; J Schwalbe; P Coplan; R Sharrar; H Guess
Journal:  Pediatr Infect Dis J       Date:  1999-12       Impact factor: 2.129

10.  Varicella susceptibility in a Canadian population.

Authors:  S Ratnam
Journal:  Can J Infect Dis       Date:  2000-09
View more
  5 in total

1.  Varicella vaccination for grades 4 and 5 students: from theory to practice.

Authors:  Paul Rivest; Lise Grenier; Guy Lonergan; Lucie Bédard
Journal:  Can J Public Health       Date:  2005 May-Jun

2.  Digital epidemiology reveals global childhood disease seasonality and the effects of immunization.

Authors:  Kevin M Bakker; Micaela Elvira Martinez-Bakker; Barbara Helm; Tyler J Stevenson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

Review 3.  Increasing Coverage of Appropriate Vaccinations: A Community Guide Systematic Economic Review.

Authors:  Verughese Jacob; Sajal K Chattopadhyay; David P Hopkins; Jennifer Murphy Morgan; Adesola A Pitan; John M Clymer
Journal:  Am J Prev Med       Date:  2016-02-01       Impact factor: 5.043

Review 4.  School-based vaccination programmes: a systematic review of the evidence on organisation and delivery in high income countries.

Authors:  Sarah Perman; Simon Turner; Angus I G Ramsay; Abigail Baim-Lance; Martin Utley; Naomi J Fulop
Journal:  BMC Public Health       Date:  2017-03-14       Impact factor: 3.295

5.  Calibration and Evaluation of Quantitative Antibody Titers for Varicella-Zoster Virus by Use of the BioPlex 2200.

Authors:  Elizabeth McLachlan; Heidi Scholz; Shelly Bolotin; Natasha S Crowcroft; Todd F Hatchette; Colleen Jackson; Alberto Severini
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.